More than 65-year-old, advanced TNM stage, history of colon polyps, KRAS mutation, lymphatic invasion, new tumor after initial treatment, and residual tumor were risk factors; and pMMR and synchronous CRC present were protective factors in univariate regression (Additional file 1: Figure S4E). This evidence concerns the gene KRAS and intestinal disorder.